رجوع
51
نطاق اليوم
KWD 41.13
KWD 43.61
نطاق 52 أسبوعًا
KWD 15.48
KWD 44.87
حجم التداول
2,090,755
متوسط 50 يوم / 200 يوم
KWD 40.00
/
KWD 31.00
الإغلاق السابق
KWD 42.10
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 44.0 | 0.3 |
| P/B | 4.5 | 2.9 |
| ROE % | 10.8 | 3.7 |
| Net Margin % | 1.5 | 3.8 |
| Rev Growth 5Y % | 17.8 | 10.0 |
| D/E | 1.5 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 44.180
+2.0%
Low: KWD 32.000
High: KWD 55.000
مكرر الربحية المستقبلي
27.1
ربحية السهم المستقبلية
KWD 1.553
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
15 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 5.240
KWD 4.907 – KWD 5.415
|
28 B | 2 |
| FY2029 |
KWD 3.610
KWD 3.380 – KWD 3.731
|
23 B | 2 |
| FY2028 |
KWD 2.596
KWD 2.267 – KWD 3.222
|
19 B | 4 |
النقاط الرئيسية
Revenue grew 17.83% annually over 5 years — strong growth
ROE of 10.82% — decent returns on equity
Generating 394.69M in free cash flow
P/E of 43.96 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.24%
Cash machine — converts 207.00% of earnings into free cash flow
النمو
Revenue Growth (5Y)
17.83%
Revenue (1Y)14.59%
Earnings (1Y)N/A
FCF Growth (3Y)69.57%
الجودة
Return on Equity
10.82%
ROIC6.29%
Net Margin1.48%
Op. Margin3.06%
الأمان
Debt / Equity
1.52
Current Ratio1.57
Interest Coverage2.51
التقييم
P/E Ratio
43.96
P/B Ratio4.47
EV/EBITDA28.16
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.59% | Revenue Growth (3Y) | 20.94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17.83% | Earnings Growth (5Y) | 39.88% |
| Profitability | |||
| Revenue (TTM) | 12.91B | Net Income (TTM) | 190.67M |
| ROE | 10.82% | ROA | 2.97% |
| Gross Margin | 11.76% | Operating Margin | 3.06% |
| Net Margin | 1.48% | Free Cash Flow (TTM) | 394.69M |
| ROIC | 6.29% | FCF Growth (3Y) | 69.57% |
| Safety | |||
| Debt / Equity | 1.52 | Current Ratio | 1.57 |
| Interest Coverage | 2.51 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 43.96 | P/B Ratio | 4.47 |
| P/S Ratio | 0.65 | PEG Ratio | -0.04 |
| EV/EBITDA | 28.16 | Dividend Yield | 0.00% |
| Market Cap | 8.38B | Enterprise Value | 11.14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 12.91B | 11.27B | 8.83B | 7.72B | 6.70B |
| Net Income | 190.67M | -18.06M | -154.60M | -53.91M | 49.80M |
| EPS (Diluted) | 0.87 | -0.09 | -0.90 | -0.31 | 0.29 |
| Gross Profit | 1.52B | 1.59B | 1.43B | 1.35B | 1.25B |
| Operating Income | 395.46M | 206.37M | 147.18M | 187.83M | 234.18M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.41B | 5.93B | 5.53B | 5.44B | 5.51B |
| Total Liabilities | 4.53B | 4.27B | 4.92B | 4.66B | 4.71B |
| Shareholders' Equity | 1.88B | 1.65B | 584.74M | 754.78M | 774.82M |
| Total Debt | 2.84B | 2.90B | 3.67B | 3.68B | 3.77B |
| Cash & Equivalents | 88.37M | 61.25M | 13.07M | 13.63M | 46.74M |
| Current Assets | 2.89B | 1.89B | 1.46B | 1.34B | 1.18B |
| Current Liabilities | 1.85B | 1.43B | 1.25B | 932.51M | 892.16M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#173 of 618
النشاط الأخير
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026